缓释茶碱(SRT):一种治疗慢性阻塞性肺病的老药,在这种慢性疾病的治疗中仍保持其优势

Amit Sharma
{"title":"缓释茶碱(SRT):一种治疗慢性阻塞性肺病的老药,在这种慢性疾病的治疗中仍保持其优势","authors":"Amit Sharma","doi":"10.37191/mapsci-2582-6549-3(1)-031","DOIUrl":null,"url":null,"abstract":"Sustained release theophylline (SRT) has been an important component in the Pharmacotherapy of Chronic Obstructive Pulmonary Disease (COPD). Recent years have witnessed a dynamic change in the treatment of this disease. Several new drugs, especially inhaled ones, have largely supplanted the oral drugs used in COPD. SRT has also been relegated to such a position that it is an option which may be used in very severe cases only on the Clinician’s discretion. The axiom that development of new drugs does not belittle the clinical edge of the previous used one is in our opinion applicable to SRT. In this abstract, we attempt to underline the importance of Sustained-Released Theophylline (SRT) in the management of COPD.The endeavour is to systematically emphasize the myriad actions of SRT which provide relief by multiple means to patients in Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD).","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sustained Release Theophylline (SRT): An Older Drug for COPD which Still Retains its Edge in the Management of this Chronic Disease\",\"authors\":\"Amit Sharma\",\"doi\":\"10.37191/mapsci-2582-6549-3(1)-031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sustained release theophylline (SRT) has been an important component in the Pharmacotherapy of Chronic Obstructive Pulmonary Disease (COPD). Recent years have witnessed a dynamic change in the treatment of this disease. Several new drugs, especially inhaled ones, have largely supplanted the oral drugs used in COPD. SRT has also been relegated to such a position that it is an option which may be used in very severe cases only on the Clinician’s discretion. The axiom that development of new drugs does not belittle the clinical edge of the previous used one is in our opinion applicable to SRT. In this abstract, we attempt to underline the importance of Sustained-Released Theophylline (SRT) in the management of COPD.The endeavour is to systematically emphasize the myriad actions of SRT which provide relief by multiple means to patients in Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD).\",\"PeriodicalId\":15543,\"journal\":{\"name\":\"Journal of Cutaneous Immunology and Allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cutaneous Immunology and Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37191/mapsci-2582-6549-3(1)-031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Immunology and Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37191/mapsci-2582-6549-3(1)-031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

缓释茶碱(SRT)已成为慢性阻塞性肺疾病(COPD)药物治疗的重要组成部分。近年来,这种疾病的治疗发生了动态变化。几种新药,尤其是吸入性药物,已经在很大程度上取代了治疗慢性阻塞性肺病的口服药物。SRT也被降级到这样一个位置,只有在临床医生的判断下,它才能在非常严重的病例中使用。我们认为,新药的开发不会削弱旧药的临床优势这一公理适用于SRT。在这篇摘要中,我们试图强调缓释茶碱(SRT)在COPD治疗中的重要性。努力是系统地强调SRT的无数行动,通过多种方式为慢性阻塞性肺疾病(AECOPD)急性加重患者提供缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sustained Release Theophylline (SRT): An Older Drug for COPD which Still Retains its Edge in the Management of this Chronic Disease
Sustained release theophylline (SRT) has been an important component in the Pharmacotherapy of Chronic Obstructive Pulmonary Disease (COPD). Recent years have witnessed a dynamic change in the treatment of this disease. Several new drugs, especially inhaled ones, have largely supplanted the oral drugs used in COPD. SRT has also been relegated to such a position that it is an option which may be used in very severe cases only on the Clinician’s discretion. The axiom that development of new drugs does not belittle the clinical edge of the previous used one is in our opinion applicable to SRT. In this abstract, we attempt to underline the importance of Sustained-Released Theophylline (SRT) in the management of COPD.The endeavour is to systematically emphasize the myriad actions of SRT which provide relief by multiple means to patients in Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.60
自引率
10.00%
发文量
69
审稿时长
12 weeks
期刊最新文献
Physicians’ perspectives and practice in atopic dermatitis management: a cross-sectional online survey in Japan Adult epidermal nevus syndrome with hypophosphatemic osteomalacia treated with burosumab: a case study and literature review Issue Information A case of myasthenia gravis following alopecia areata The presence of neutrophil extracellular traps in different forms of pyoderma gangrenosum
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1